Resources Contact Us Home
Formulation of quinazoline based EGFR inhibitors containing a zinc binding moiety

Image Number 13 for United States Patent #8119616.

The present invention relates to a composition comprising an inclusion complex of a cyclodextrin and quinazoline containing zinc-binding moiety based derivatives. The cyclodextrin is preferable a .beta.-cyclodextrin or a derivative thereof. The quinazolines have enhanced and unexpected properties as inhibitors of epidermal growth factor receptor tyrosine kinase (EGFR-TK) and their use in the treatment of EGFR-TK related diseases and disorders such as cancer. The said derivatives may further act as HDAC inhibitors.

  Recently Added Patents
Output device, source apparatus, television set, system, output method, program, and recording medium
Fractal method for detecting and filling data gaps within LiDAR data
Image capturing apparatus, control method thereof, and program
Image processing apparatus and image processing method
Modular authoring and visualization of rules using trees
Front exterior of an automotive tail lamp
Device and method including a soldering process
  Randomly Featured Patents
Method for forming a metal silicide
Technology dependent transformations for CMOS in digital design synthesis
CVD method of forming self-lubricating composites
Modular display package
Information processing apparatus and communication path selection method
Fluid jet shuttleless loom with resistance providing means for weft yarn
Print hammer
Display cabinet illumination
DC electric arc melting apparatus
Platelet activation protein